Figure S1. Survival was analyzed according to pCR. Among breast cancer cases, DFS was significantly better in the pCR group compared with the non-pCR group (p = 0.040) (a) and OS tended to be better in the pCR group (p = 0.058) (b). (TIF 118 kb
The correlation diagrams of CD8 + TIL, FOXP3 + TIL, and CD8/FOXP3 ratio with residual cancer burden ...
Multivariate analysis model 2 predicting overall survival using platelet-lymphocyte- ratio (PLR). (X...
The relationship between the NLR status and cancer-specific survival in patients with OSCC. In the K...
Figure S2. ROC curve analyses of the LMR and NLR in breast cancer patients. The LMR cut-off value fo...
Figure S3. Correlation between clinicopathological features and LMR in 239 all breast cancers in con...
Table S1. Univariate- and multivariate analysis with respect to disease-free survival in 83 triple-n...
Figure S4. Correlation between clinicopathological features and NLR in 239 all breast cancers in con...
Figure S1. KaplanâMeier survival analysis of baseline hematologic parameters (NLR, PLR), TILs CD8+...
Table S1. Univariate and multivariate Cox regression analyses of TILs, LMR, and clinicopathological ...
Recurrence-free survival (RFS) and breast cancer-specific survival (BCSS) in patients with different...
Figure S1. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
Analysis of RCB-TILs status and outcome in breast cancer (Overall Survival, OS). OS was significantl...
Table S1. Levels of peripheral blood lymphocytes of different subtypes do not differ in breast cance...
The relationships between the NLR status and cancer-specific survival in patients with OSCC. In the ...
Recurrence-free survival (RFS) and breast cancer-specific survival (BCSS) in patients with different...
The correlation diagrams of CD8 + TIL, FOXP3 + TIL, and CD8/FOXP3 ratio with residual cancer burden ...
Multivariate analysis model 2 predicting overall survival using platelet-lymphocyte- ratio (PLR). (X...
The relationship between the NLR status and cancer-specific survival in patients with OSCC. In the K...
Figure S2. ROC curve analyses of the LMR and NLR in breast cancer patients. The LMR cut-off value fo...
Figure S3. Correlation between clinicopathological features and LMR in 239 all breast cancers in con...
Table S1. Univariate- and multivariate analysis with respect to disease-free survival in 83 triple-n...
Figure S4. Correlation between clinicopathological features and NLR in 239 all breast cancers in con...
Figure S1. KaplanâMeier survival analysis of baseline hematologic parameters (NLR, PLR), TILs CD8+...
Table S1. Univariate and multivariate Cox regression analyses of TILs, LMR, and clinicopathological ...
Recurrence-free survival (RFS) and breast cancer-specific survival (BCSS) in patients with different...
Figure S1. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
Analysis of RCB-TILs status and outcome in breast cancer (Overall Survival, OS). OS was significantl...
Table S1. Levels of peripheral blood lymphocytes of different subtypes do not differ in breast cance...
The relationships between the NLR status and cancer-specific survival in patients with OSCC. In the ...
Recurrence-free survival (RFS) and breast cancer-specific survival (BCSS) in patients with different...
The correlation diagrams of CD8 + TIL, FOXP3 + TIL, and CD8/FOXP3 ratio with residual cancer burden ...
Multivariate analysis model 2 predicting overall survival using platelet-lymphocyte- ratio (PLR). (X...
The relationship between the NLR status and cancer-specific survival in patients with OSCC. In the K...